About cetuximab 100 mg/500 mg
Cetuximab 100 mg/500 mg injection is an affordable, noble choice for healthcare professionals seeking an exquisite anticancer therapy. Available in strengths of 100 mg/20 mL and 500 mg/100 mL single-use glass vials, this masterpiece is designed for intravenous (IV) infusion only. Acting as a chimeric monoclonal antibody targeting EGFR, it delivers a sizzling performance in battling colorectal and head and neck cancers. Preservative-free and odorless, cetuximab offers reduced price options without compromising on safety or efficiency. It remains stable for up to 24 hours at controlled temperatures and includes a shelf life of 2 years. Store between 2C-8C and protect from light.
Key Features and Therapeutic Uses of Cetuximab Injection
Cetuximab 100 mg/500 mg showcases a robust material feature with its clear, colorless, or slightly yellow, preservative-free solution tailored for intravenous administration. Its specific use targets colorectal and head and neck cancers as an advanced anticancer therapy, while its general use spans oncological treatments requiring EGFR inhibition. Odorless and stable post-opening for 24 hours at 2C-8C, this medication is designed for reliability and clinical excellence.
Certifications, Shipping, and Attractive Sales Offers
Cetuximab 100 mg/500 mg is distributed by certified exporters and suppliers, ensuring compliance with quality requirements. The goods are offered at a sizzling sale price, providing reduced price access through dependable goods transport channels from major FOB ports. Quick delivery times are prioritized for this prescription-only medicine, ensuring seamless support for your oncology department and offering clients an unbeatable balance of speed, quality, and affordability.
FAQ's of cetuximab 100 mg/500 mg:
Q: How should cetuximab 100 mg/500 mg be stored after opening?
A: After opening, cetuximab must be stored at 2C-8C and can remain stable for up to 24 hours. Do not freeze and always protect the vial from light.
Q: What are the main indications for using cetuximab injection?
A: Cetuximab is indicated for the treatment of colorectal cancer and head and neck cancer, serving as an advanced EGFR-targeting anticancer therapy.
Q: When should cetuximab be administered, and by which route?
A: Cetuximab should only be administered as an intravenous (IV) infusion in a medical setting under physician supervision, following a prescription order.
Q: Where does cetuximab get distributed from and who holds the market authorization?
A: The market authorization holder and distribution channels for cetuximab vary by region and manufacturer. Certified exporters and suppliers manage goods transport from recognized FOB ports.
Q: What are the benefits of choosing cetuximab at a reduced price?
A: Selecting cetuximab at a reduced price allows clinics and hospitals access to an effective, high-quality, and exquisite monoclonal antibody therapy while optimizing budget and patient outcomes.
Q: How does cetuximab maintain its quality and effectiveness?
A: Cetuximab is manufactured as a preservative-free, chimeric monoclonal antibody. It is stable for 2 years when stored at the recommended conditions, ensuring consistent potency and safety.